Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$89,823,184
+$50,217,968 QoQ
Shares Held
1,427,124
+152.8% QoQ
Ownership
3.25%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#10
of 256 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Derivatives in TARS
reported options exposure · as of Jun 30, 2026CallValue
$1,888,200
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. TARS ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in TARS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,823,184 | 1,427,124 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,888,200 | 30,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $39,605,216 | 564,579 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $2,104,500 | 30,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $1,637,600 | 20,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $9,580,287 | 117,004 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,976,756 | 100,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,355,291 | 58,141 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,698,407 | 247,195 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,658,833 | 644,010 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,318,518 | 222,515 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,474,567 | 348,586 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $932,159 | 25,644 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,018,693 | 198,454 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,361,020 | 808,161 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,277,043 | 70,672 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $168,274 | 13,387 | Shares | Sole | 2023-05-15 | |
| 2021-03-31 | $2,734,844 | 84,854 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,961,273 | 144,236 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||